SCHEMBL27007648

SCHEMBL27007648

NN(C(=O)c1ccc(Br)c(F)c1)C(=O)c1ccc(Br)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.41
HDAC1 Q13547 3/20 0.40
HDAC6 Q9UBN7 3/20 0.40
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
MAOB P27338 1/20 0.38
HPGD P15428 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KDM1A O60341 2/20 0.36
KCNH2 Q12809 2/20 0.36
KDM1B Q8NB78 1/20 0.36
SLC6A4 P31645 1/20 0.35
IDO1 P14902 1/20 0.35
DGAT1 O75907 1/20 0.34
ERN1 O75460 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27007966 0.93 KIF11 (0.41) KIF11HDAC1HDAC6CES2CES1
SCHEMBL27007825 0.87 DGAT1 (0.50) KIF11CES2CES1NPC1RAB9A
SCHEMBL850387 0.81 ERN1 (0.44) KIF11HDAC1HDAC6CES2CES1
SCHEMBL27007852 0.79 MAPT (0.50) HPGDNPC1RAB9A
SCHEMBL356759 0.79 KIF11 (0.49) KIF11HDAC1HDAC6CES2CES1
SCHEMBL27002437 0.77 NPSR1 (0.51) KIF11HDAC1HDAC6CES2CES1
SCHEMBL10266907 0.77 HPGD (0.64) HPGDNPC1RAB9A
SCHEMBL286942 0.76 HTT (0.53) KIF11CES2CES1MAOBHPGD
SCHEMBL30523532 0.76 HTT (0.53) KIF11CES2CES1MAOBHPGD
SCHEMBL589423 0.76 MLYCD (0.48) KIF11HDAC1HDAC6CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018121-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE FOX CHASE CHEMCIAL DIVERSITY CENTER, INC. (US) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018121-A1 NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE ERG28, CYP51A1, MANBA KIF11 4286/4885HDAC1 251/4885HDAC6 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.